Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription

  • Wierer, Michael, 1982-
  • Verde, Gaetano
  • Pisano, Paola
  • Molina, Henrik
  • Font Mateu, Jofre, 1977-
  • Di Croce, Luciano
  • Beato, Miguel
Polo-like kinase 1 (PLK1) is a key regulator of cell division and is overexpressed in many types of human cancers. Compared to its well-characterized role in mitosis, little is known about PLK1 functions in interphase. Here, we report that PLK1 mediates estrogen receptor (ER)-regulated gene transcription in human breast cancer cells. PLK1 interacts with ER and is recruited to ER cis-elements on chromatin. PLK1-coactivated genes included classical ER target genes such as Ps2, Wisp2, and Serpina3 and were enriched in developmental and tumor-suppressive functions. Performing large-scale phosphoproteomics of estradiol-treated MCF7 cells in the presence or absence of the specific PLK1 inhibitor BI2536, we identified several PLK1 end targets involved in transcription, including the histone H3K4 trimethylase MLL2, the function of which on ER target genes was impaired by PLK1 inhibition. Our results propose a mechanism for the tumor-suppressive role of PLK1 in mammals as an interphase transcriptional regulator., We would like to thank Thorsten Berg for kindly providing the Poloxin compound; Johan Staaf for the preprocessed 1,881-sample breast tumor data set; Giancarlo Castellano, Sarah Bonnin, and Andrew Pohl for bioinformatic support; Alessandra Ciociola and Roni Wright for experimental help; and Juan Valcarcel for critically reading the manuscript. Mass spectrometry, microarray, and cell sorting analyses were performed at the UPF/CRG proteomic, microarray, and flow cytometry core facilities, respectively. G.V. has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 299429 and from the European Molecular Biology Organization (EMBO long-term fellowship ALTF 1106-2011, cofunded with the European Commission EMBOCOFUND2010, GA-2010-267146). This study was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Nucleosome-driven transcription factor binding and gene regulation

  • Ballaré, Cecilia Julia
  • Castellano, Giancarlo
  • Gaveglia, Laura
  • Althammer, Sonja Daniela
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Le Dily, François
  • Zaurín Quer, Roser
  • Soronellas, Daniel
  • Vicent, Guillermo P.
  • Beato, Miguel
In fission yeast cells, Cds1 is the effector kinase of the DNA replication checkpoint. We previously showed that when the DNA replication checkpoint is activated, the repressor Yox1 is phosphorylated and inactivated by Cds1, resulting in activation of MluI-binding factor (MBF)-dependent transcription. This is essential to reinitiate DNA synthesis and for correct G1-to-S transition. Here we show that Cdc10, which is an essential part of the MBF core, is the target of the DNA damage checkpoint. When fission yeast cells are treated with DNA-damaging agents, Chk1 is activated and phosphorylates Cdc10 at its carboxy-terminal domain. This modification is responsible for the repression of MBF-dependent transcription through induced release of MBF from chromatin. This inactivation of MBF is important for survival of cells challenged with DNA-damaging agents. Thus Yox1 and Cdc10 couple normal cell cycle regulation in unperturbed conditions and the DNA replication and DNA damage checkpoints into a single transcriptional complex., The experimental work was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR). L.G. was a recipient of a fellowship from the International PhD program of LaCaixa; G.P.V. was a recipient of a fellowship from the Ramón y Cajal program.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells

  • Wright, Roni H.G.
  • Castellano, Giancarlo
  • Bonet Martínez, Jaume, 1982-
  • Le Dily, François
  • Font Mateu, Jofre, 1977-
  • Ballaré, Cecilia Julia
  • Nacht, A. Silvina
  • Soronellas, Daniel
  • Oliva Miguel, Baldomero
  • Beato, Miguel
Eukaryotic gene regulation implies that transcription factors gain access to genomic information via poorly understood processes involving activation and targeting of kinases, histone-modifying enzymes, and chromatin remodelers to chromatin. Here we report that progestin gene regulation in breast cancer cells requires a rapid and transient increase in poly-(ADP)-ribose (PAR), accompanied by a dramatic decrease of cellular NAD that could have broad implications in cell physiology. This rapid increase in nuclear PARylation is mediated by activation of PAR polymerase PARP-1 as a result of phosphorylation by cyclin-dependent kinase CDK2. Hormone-dependent phosphorylation of PARP-1 by CDK2, within the catalytic domain, enhances its enzymatic capabilities. Activated PARP-1 contributes to the displacement of histone H1 and is essential for regulation of the majority of hormone-responsive genes and for the effect of progestins on cell cycle progression. Both global chromatin immunoprecipitation (ChIP) coupled with deep sequencing (ChIP-seq) and gene expression analysis show a strong overlap between PARP-1 and CDK2. Thus, progestin gene regulation involves a novel signaling pathway that connects CDK2-dependent activation of PARP-1 with histone H1 displacement. Given the multiplicity of PARP targets, this new pathway could be used for the pharmacological management of breast cancer., The experimental work was supported by grants from the Departament d’Innovació Universitat i Empresa (DIUiE), Ministerio de Educación y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049), Fondo de Investigación Sanitaria (FIS) PI0411605 and CP04/00087, FEDER BIO2008-0205, and EU IP HEROIC.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin

  • Vallejo, Griselda
  • La Greca, Alejandro D.
  • Tarifa-Reischle, Inti C.
  • Mestre-Citrinovitz, Ana C.
  • Ballaré, Cecilia Julia
  • Beato, Miguel
  • Saragüeta, Patricia
Although non-genomic steroid receptor pathways have been studied over the past decade, little is known about the direct gene expression changes that take place as a consequence of their activation. Progesterone controls proliferation of rat endometrial stromal cells during the peri-implantation phase of pregnancy. We showed that picomolar concentration of progestin R5020 mimics this control in UIII endometrial stromal cells via ERK1-2 and AKT activation mediated by interaction of Progesterone Receptor (PR) with Estrogen Receptor beta (ERb) and without transcriptional activity of endogenous PR and ER. Here we identify early downstream targets of cytoplasmic PR signaling and their possible role in endometrial stromal cell proliferation. Microarray analysis of global gene expression changes in UIII cells treated for 45 min with progestin identified 97 up- and 341 down-regulated genes. The most over-represented molecular functions were transcription factors and regulatory factors associated with cell proliferation and cell cycle, a large fraction of which were repressors down-regulated by hormone. Further analysis verified that progestins regulate Ccnd1, JunD, Usf1, Gfi1, Cyr61, and Cdkn1b through PR-mediated activation of ligand-free ER, ERK1-2 or AKT, in the absence of genomic PR binding. ChIP experiments show that progestin promoted the interaction of USF1 with the proximal promoter of the Cdc2 gene. Usf1 knockdown abolished Cdc2 progestin-dependent transcriptional regulation and cell proliferation, which also blocked Cdc2 knockdown. We conclude that progestin-induced proliferation of endometrial stromal cells is mediated by ERK1-2 and AKT dependent early regulation of USF1, which directly induces Cdc2. To our knowledge, this is the first description of early target genes of progestin-activated classical PR via crosstalk with protein kinases and independently of hormone receptor binding to the genomic targets., This work was supported by grants to P.S. from Agencia Nacional de Promoción Científica y Tecnológica (PICT 5-34086 and PID 88) Argentina and Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 2005-2006); and to M.B. from the Ministerio de Educación y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nucleosome-driven transcription factor binding and gene regulation

  • Ballaré, Cecilia Julia
  • Castellano, Giancarlo
  • Gaveglia, Laura
  • Althammer, Sonja Daniela
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Le Dily, François
  • Zaurín Quer, Roser
  • Soronellas, Daniel
  • Vicent, Guillermo P.
  • Beato, Miguel
In fission yeast cells, Cds1 is the effector kinase of the DNA replication checkpoint. We previously showed that when the DNA replication checkpoint is activated, the repressor Yox1 is phosphorylated and inactivated by Cds1, resulting in activation of MluI-binding factor (MBF)-dependent transcription. This is essential to reinitiate DNA synthesis and for correct G1-to-S transition. Here we show that Cdc10, which is an essential part of the MBF core, is the target of the DNA damage checkpoint. When fission yeast cells are treated with DNA-damaging agents, Chk1 is activated and phosphorylates Cdc10 at its carboxy-terminal domain. This modification is responsible for the repression of MBF-dependent transcription through induced release of MBF from chromatin. This inactivation of MBF is important for survival of cells challenged with DNA-damaging agents. Thus Yox1 and Cdc10 couple normal cell cycle regulation in unperturbed conditions and the DNA replication and DNA damage checkpoints into a single transcriptional complex., The experimental work was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR). L.G. was a recipient of a fellowship from the International PhD program of LaCaixa; G.P.V. was a recipient of a fellowship from the Ramón y Cajal program.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells

  • Wright, Roni H.G.
  • Castellano, Giancarlo
  • Bonet Martínez, Jaume, 1982-
  • Le Dily, François
  • Font Mateu, Jofre, 1977-
  • Ballaré, Cecilia Julia
  • Nacht, A. Silvina
  • Soronellas, Daniel
  • Oliva Miguel, Baldomero
  • Beato, Miguel
Eukaryotic gene regulation implies that transcription factors gain access to genomic information via poorly understood processes involving activation and targeting of kinases, histone-modifying enzymes, and chromatin remodelers to chromatin. Here we report that progestin gene regulation in breast cancer cells requires a rapid and transient increase in poly-(ADP)-ribose (PAR), accompanied by a dramatic decrease of cellular NAD that could have broad implications in cell physiology. This rapid increase in nuclear PARylation is mediated by activation of PAR polymerase PARP-1 as a result of phosphorylation by cyclin-dependent kinase CDK2. Hormone-dependent phosphorylation of PARP-1 by CDK2, within the catalytic domain, enhances its enzymatic capabilities. Activated PARP-1 contributes to the displacement of histone H1 and is essential for regulation of the majority of hormone-responsive genes and for the effect of progestins on cell cycle progression. Both global chromatin immunoprecipitation (ChIP) coupled with deep sequencing (ChIP-seq) and gene expression analysis show a strong overlap between PARP-1 and CDK2. Thus, progestin gene regulation involves a novel signaling pathway that connects CDK2-dependent activation of PARP-1 with histone H1 displacement. Given the multiplicity of PARP targets, this new pathway could be used for the pharmacological management of breast cancer., The experimental work was supported by grants from the Departament d’Innovació Universitat i Empresa (DIUiE), Ministerio de Educación y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049), Fondo de Investigación Sanitaria (FIS) PI0411605 and CP04/00087, FEDER BIO2008-0205, and EU IP HEROIC.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription

  • Wierer, Michael, 1982-
  • Verde, Gaetano
  • Pisano, Paola
  • Molina, Henrik
  • Font Mateu, Jofre, 1977-
  • Di Croce, Luciano
  • Beato, Miguel
Polo-like kinase 1 (PLK1) is a key regulator of cell division and is overexpressed in many types of human cancers. Compared to its well-characterized role in mitosis, little is known about PLK1 functions in interphase. Here, we report that PLK1 mediates estrogen receptor (ER)-regulated gene transcription in human breast cancer cells. PLK1 interacts with ER and is recruited to ER cis-elements on chromatin. PLK1-coactivated genes included classical ER target genes such as Ps2, Wisp2, and Serpina3 and were enriched in developmental and tumor-suppressive functions. Performing large-scale phosphoproteomics of estradiol-treated MCF7 cells in the presence or absence of the specific PLK1 inhibitor BI2536, we identified several PLK1 end targets involved in transcription, including the histone H3K4 trimethylase MLL2, the function of which on ER target genes was impaired by PLK1 inhibition. Our results propose a mechanism for the tumor-suppressive role of PLK1 in mammals as an interphase transcriptional regulator., We would like to thank Thorsten Berg for kindly providing the Poloxin compound; Johan Staaf for the preprocessed 1,881-sample breast tumor data set; Giancarlo Castellano, Sarah Bonnin, and Andrew Pohl for bioinformatic support; Alessandra Ciociola and Roni Wright for experimental help; and Juan Valcarcel for critically reading the manuscript. Mass spectrometry, microarray, and cell sorting analyses were performed at the UPF/CRG proteomic, microarray, and flow cytometry core facilities, respectively. G.V. has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 299429 and from the European Molecular Biology Organization (EMBO long-term fellowship ALTF 1106-2011, cofunded with the European Commission EMBOCOFUND2010, GA-2010-267146). This study was supported by grants from the Spanish government (BMC 2003-02902 and 2010-15313; CSD2006-00049), the European Union (IP HEROIC), and the Catalan government (AGAUR).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin

  • Vallejo, Griselda
  • La Greca, Alejandro D.
  • Tarifa-Reischle, Inti C.
  • Mestre-Citrinovitz, Ana C.
  • Ballaré, Cecilia Julia
  • Beato, Miguel
  • Saragüeta, Patricia
Although non-genomic steroid receptor pathways have been studied over the past decade, little is known about the direct gene expression changes that take place as a consequence of their activation. Progesterone controls proliferation of rat endometrial stromal cells during the peri-implantation phase of pregnancy. We showed that picomolar concentration of progestin R5020 mimics this control in UIII endometrial stromal cells via ERK1-2 and AKT activation mediated by interaction of Progesterone Receptor (PR) with Estrogen Receptor beta (ERb) and without transcriptional activity of endogenous PR and ER. Here we identify early downstream targets of cytoplasmic PR signaling and their possible role in endometrial stromal cell proliferation. Microarray analysis of global gene expression changes in UIII cells treated for 45 min with progestin identified 97 up- and 341 down-regulated genes. The most over-represented molecular functions were transcription factors and regulatory factors associated with cell proliferation and cell cycle, a large fraction of which were repressors down-regulated by hormone. Further analysis verified that progestins regulate Ccnd1, JunD, Usf1, Gfi1, Cyr61, and Cdkn1b through PR-mediated activation of ligand-free ER, ERK1-2 or AKT, in the absence of genomic PR binding. ChIP experiments show that progestin promoted the interaction of USF1 with the proximal promoter of the Cdc2 gene. Usf1 knockdown abolished Cdc2 progestin-dependent transcriptional regulation and cell proliferation, which also blocked Cdc2 knockdown. We conclude that progestin-induced proliferation of endometrial stromal cells is mediated by ERK1-2 and AKT dependent early regulation of USF1, which directly induces Cdc2. To our knowledge, this is the first description of early target genes of progestin-activated classical PR via crosstalk with protein kinases and independently of hormone receptor binding to the genomic targets., This work was supported by grants to P.S. from Agencia Nacional de Promoción Científica y Tecnológica (PICT 5-34086 and PID 88) Argentina and Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 2005-2006); and to M.B. from the Ministerio de Educación y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.